{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-008475","form_type":"8-K","ticker":"BIXT","cik":"0001445815","company_name":"BIOXYTRAN, INC","filed_at":"2026-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.101015+00:00","generated_at":"2026-05-15T22:35:14.300772+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Bioxytran's ProLectin-M achieves 90% Day-5 viral clearance in Phase 1b/2a COVID-19 study","bullets":["Phase 1b/2a trial: 39 patients; highest dose 16,800 mg/day showed 90% Day-5 viral clearance vs 20% placebo (p=0.001).","90% of highest-dose cohort had ≥2-point improvement on WHO Ordinal Scale by Day 5 vs 20% placebo.","No serious adverse events, no treatment-related discontinuations; favorable safety profile across all doses.","ProLectin-M targets galectins to block viral entry; potential broad-range antiviral beyond COVID-19.","Company plans larger studies to evaluate ProLectin-M as first-line oral antiviral therapy."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-008475","json":"https://secwatch.observer/filing/0001493152-26-008475.json","markdown":"https://secwatch.observer/filing/0001493152-26-008475.md","text":"https://secwatch.observer/filing/0001493152-26-008475.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1445815/000149315226008475/0001493152-26-008475-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1445815/000149315226008475/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:35:14.300772+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}